Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Proteomes 2013, 1(2), 109-127; doi:10.3390/proteomes1020109
Review

Proteomic Workflows for Biomarker Identification Using Mass Spectrometry — Technical and Statistical Considerations during Initial Discovery

1
 and 2,*
Received: 27 June 2013; in revised form: 22 August 2013 / Accepted: 22 August 2013 / Published: 27 August 2013
(This article belongs to the Special Issue Insights and Trends into Proteome Science)
View Full-Text   |   Download PDF [641 KB, uploaded 27 August 2013]   |   Browse Figures
Abstract: Identification of biomarkers capable of differentiating between pathophysiological states of an individual is a laudable goal in the field of proteomics. Protein biomarker discovery generally employs high throughput sample characterization by mass spectrometry (MS), being capable of identifying and quantifying thousands of proteins per sample. While MS-based technologies have rapidly matured, the identification of truly informative biomarkers remains elusive, with only a handful of clinically applicable tests stemming from proteomic workflows. This underlying lack of progress is attributed in large part to erroneous experimental design, biased sample handling, as well as improper statistical analysis of the resulting data. This review will discuss in detail the importance of experimental design and provide some insight into the overall workflow required for biomarker identification experiments. Proper balance between the degree of biological vs. technical replication is required for confident biomarker identification.
Keywords: biomarker discovery; experimental design; randomization; replication; high dimensional data biomarker discovery; experimental design; randomization; replication; high dimensional data
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Orton, D.J.; Doucette, A.A. Proteomic Workflows for Biomarker Identification Using Mass Spectrometry — Technical and Statistical Considerations during Initial Discovery. Proteomes 2013, 1, 109-127.

AMA Style

Orton DJ, Doucette AA. Proteomic Workflows for Biomarker Identification Using Mass Spectrometry — Technical and Statistical Considerations during Initial Discovery. Proteomes. 2013; 1(2):109-127.

Chicago/Turabian Style

Orton, Dennis J.; Doucette, Alan A. 2013. "Proteomic Workflows for Biomarker Identification Using Mass Spectrometry — Technical and Statistical Considerations during Initial Discovery." Proteomes 1, no. 2: 109-127.

Proteomes EISSN 2227-7382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert